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Abstract 
Background: The VACTERL association is a typically sporadic, non-random collection of congenital anomalies that 
includes vertebral defects, anal atresia, cardiac defects, tracheoesophageal fistula with esophageal atresia, renal anom-
alies, and limb abnormalities. Although several chromosomal aberrations and gene mutations have been reported as 
disease-causative, these findings have been sparsely replicated to date.
Case presentation: In the present study, whole exome sequencing of a case with the VACTERL association uncov-
ered a novel frameshift mutation in the PCSK5 gene, which has been reported as one of the causative genes for the 
VACTERL association. Although this mutation appears potentially pathogenic in its functional aspects, it was also 
carried by the healthy father. Furthermore, a database survey revealed several other deleterious variants in the PCSK5 
gene in the general population.
Conclusions: Further studies are necessary to clarify the etiological role of the PCSK5 mutation in the VACTERL 
association.
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Background
The VACTERL association (OMIM #192350) is a con-
genital disease characterized by the presence of at least 
three of the conditions of vertebral defects, anal atre-
sia, cardiac defects, tracheoesophageal fistula, renal 
anomalies, and limb abnormalities. The VACTERL asso-
ciation occurs sporadically with a heterogeneous back-
ground, and its incidence is estimated at approximately 
1 in 10,000 to 1 in 40,000 live-born infants [1]. The 
etiology of the VACTERL association is not still fully 
understood, although HOXD13, ZIC3, PTEN, FANCB, 
FOXF1, and TRAP1 mutations have been reported as 
possible contributors to the VACTERL association or 
the VACTERL-like association as described previously 
[2–9]. Several microduplications and microdeletions are 
also reportedly associated with the VACTERL associa-
tion [10, 11]. However, these findings have had sparsely 
be replicated.
Whole exome sequencing (WES) is a powerful tool in 
the investigation of genomic bases of human diseases. 
WES covers more than 95% of the exons of human genes, 
and 85% of the disease-causing mutations in Mendelian 
disorders are identified therein. In addition, many dis-
ease-associated single nucleotide polymorphisms (SNPs) 
are also located in this portion of the genome. Accord-
ingly, WES is expected to provide information on nearly 
all functional, protein-coding regions in individuals with 
agnogenic congenital disorders [12, 13].
In this study, we analyzed a Japanese patient with the 
VACTERL association and his parents by WES and 
identified a novel frameshift mutation in the PCSK5 
gene. Since several non-synonymous variants in the 
cysteine-rich motif (CRM) of the PCSK5 gene have been 
described in patients with the VACTERL association as 
a potentially responsible gene for this condition [14, 15], 
Open Access
*Correspondence:  yxn14@aol.jp 
1 Department of Orthopaedic Surgery, Shinshu University School 
of Medicine, Matsumoto, Japan
Full list of author information is available at the end of the article
Page 2 of 7Nakamura et al. BMC Res Notes  (2015) 8:228 
we further studied the causal role of the PCSK5 mutation 
in the VACTERL association.
Case presentation
A 10-year-old Japanese boy with the Fallot tetralogy (ven-
tricular septal defect, branch pulmonary artery stenosis, 
right ventricular hypertrophy, and aortic overriding), 
congenital scoliosis affecting the eighth thoracic hemiver-
tebra, unilateral renal anomaly of the right kidney, limb 
anomalies and dislocation of the right knee, and cho-
roidal coloboma was referred to our institution. On the 
basis of four out of seven component features, the patient 
was diagnosed as having the VACTERL association by 
a board-certified pediatrician. The patient was born by 
vaginal delivery following a gestation period of 37 weeks 
and weighed 2,740  g at birth. He underwent heart sur-
gery using a Rastelli procedure when he was 2  years of 
age. Since then, he has led a normal life apart from the 
abstinence of vigorous exercise. The parent’s family histo-
ries were unremarkable. There was no maternal or pater-
nal history of congenital malformations, hypertension, 
diabetes, miscarriage, or consanguineous marriage.
Methods
Subjects
We analyzed the case of a Japanese boy with the VACTERL 
association based on the presence of four out of seven 
component features as determined by a board-certified 
pediatrician at our institution. After informed consent 
was obtained, peripheral blood samples were taken from 
the patient and his parents. Our study was approved by the 
Ethical Review Board for Human Genome Studies at Shin-
shu University School of Medicine.
Exome capture and sequencing
A total of 3 μg of genomic DNA obtained from peripheral 
leukocytes of the patient and his parents was subjected to 
an exome capture procedure using the Agilent Sure Select 
Human All Exon Kit V5 (Agilent Technology, Tokyo) (tar-
get size: 50 megabases [Mb]) according to the manufac-
turer’s protocols. Briefly, genomic DNA was fragmented 
with Covaris (Covaris Inc., MA, USA) and purified using 
Agencourt AMPure XP beads (Beckman Coulter Inc., 
Tokyo). The quality of the fragmentation and purifica-
tion was assessed with an Agilent 2100 Bioanalyzer. The 
fragment ends were repaired, an adenosine residue was 
added to the 3′ end of the fragments, and then SureSelect 
adaptors were ligated to the fragments using an Agilent 
SureSelect Library Prep Kit, ILM. At each step, the frag-
ments were purified using Agencourt AMPure XP beads. 
The DNA libraries were amplified by PCR following qual-
ity confirmation. Exon-containing fragments were cap-
tured by biotinylated RNA library “baits” using an Agilent 
SureSelect Target Enrichment Kit. The captured DNA 
was purified with streptavidin-coated magnetic beads and 
re-amplified. The DNA libraries of the patient and his par-
ents were sequenced using the illumina HiSeq system in 
101-base-pair (bp) paired-end reads.
Alignment and variant calling
Sequence reads were aligned to the human reference 
genome (GRCh37/hg19 + decoy sequences) obtained from 
the 1000 Genomes FTP site (ftp://1000genomes.ebi.ac.uk/) 
using the Burrows-Wheeler Aligner (BWA) version 0.6.2 
[16]. Multiple identical reads from the exact same frag-
ment were marked as duplicates and removed using Picard 
Tools version 1.8.3 (http://picard.sourceforge.net.). Exome 
target regions of the SureSelect V5 were downloaded from 
the Agilent SureDesign website (https://earray.chem.agi-
lent.com/suredesign/) for calculation of read depth to 
assess coverage. Sequence data and coverage are shown 
in Additional file 1: Table  S1. Local realignment around 
known indels, base quality score recalibration (BQSR), and 
variant calling using UnifiedGenotyper variant caller were 
performed with the Genome Analysis Toolkit (GATK) 2 
version 2013.2 obtained from the Appistry website (http://
www.appistry.com/gatk). Variant quality score recalibration 
(VQSR) using the GATK was performed to filter out false 
positive variants. This method builds a probabilistic model 
from a training set of known true mutations and assigns an 
accurate confidence score to each putative mutation call. 
The workflow of the GATK and its parameters were car-
ried out as recommended by the GATK best practice guide 
(http://www.appistry.com/gatk).
Additional WES Data for variant filtering and VQSR
We previously sequenced the genomes of 30 Japanese 
people, including 19 apparently healthy individuals. We 
included these data in our variant analysis since: (1) muta-
tions found in the genomes of healthy individuals are not 
likely disease-causing and therefore are usable for further 
variant filtering; and (2) the VQSR of GATK requires at 
least 30 WES samples to achieve optimal results according 
to the GATK best practice guide. With these extra subjects, 
a total of 33 samples were available for variant analysis.
Variant annotation, filtering, and family‑based analysis
Functional annotations of the Ensembl database GRCh37.70 
[17] and the possible effects of variants were added using 
SnpEff version 3.2 [18]. Using these annotations, VQSR-
passing variants were filtered first for those that were pre-
dicted to alter amino acid sequences (missense, nonsense, 
and splice-site mutations and indels in coding regions), and 
then for those that were rare (<1.0% Minor Allele Frequen-
cies [MAF] in the HapMap-JPT [Japanese in Tokyo, Japan] 
or the 1000 Genomes ASN [the East Asian population, 
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composed mostly of Japanese and Chinese] databases). 
The filtering procedure of variants and their numbers are 
presented in Additional file 1: Table S1. Genetic mutations 
classified as de novo, dominant, or recessive (homozygotes 
or compound heterozygotes) were identified by trio-family-
based analysis using an in-house script. The variants were 
also compared with the recently-released Human Genetic 
Variation Database (HGVD) (http://www.genome.med.
kyoto-u.ac.jp/SnpDB/), which contained genetic variations 
determined by WES in 1,208 Japanese individuals.
Variant validation
The variants identified via WES were confirmed using the 
Sanger method. Primer sequences were designed using 
Primer-BLAST [19]. PCR-amplified fragments were puri-
fied and then sequenced using an ABI3730xl DNA Ana-
lyzer (Life Technologies, Tokyo). Sequence data were 
analyzed with Sequence Scanner software version 1.0 
(Life Technologies, Tokyo).
Results
Variant filtering, family‑based analysis, and validation 
by Sanger sequencing
After the removal of variants that did not affect protein 
amino acid sequences or were common (≥1.0% MAF in 
HapMap-JPT or 1000 Genomes ASN databases) [20, 21], 
we analyzed the patient with the VACTERL association 
and his parents to identify genetically functional variants 
using the following classifications: (1) de novo mutations 
that were non-inherited or unique; (2) homozygous reces-
sive mutations that were derived from both parents; and (3) 
compound heterozygous mutations for which the patient 
had at least two mutations derived separately from parents 
in the same gene. Two de novo mutations in two genes, one 
homozygous recessive mutation in one gene, and four com-
pound heterozygote mutations in one gene in the patient 
were identified and validated by following Sanger sequenc-
ing (Additional file 1: Table S1). These mutations were not 
found in our in-house database of previously seqenced 
WES data obtained from 19 healthy Japanese individuals.
The identified two de novo mutations included a non-
sense mutation in the NT5C3L (5′-nucleotidase, cyto-
solic III-like) gene and a missense mutation in the TTLL9 
(tubulin tyrosine ligase-like family, member 9) gene. 
However, since both genes are functionally unknown, we 
could not conclusively determine their contribution to 
the VACTERL association.
WES identified a novel frameshift mutation in the PCSK5 
gene
Among the candidates for recessive mutations, we focused 
on the PCSK5 gene, which has been reported as one of 
the causative genes for the VACTERL association [9, 
10]. We identified a novel frameshift mutation and three 
missense mutations as a compound heterozygote in the 
PCSK5 gene in the patient that were validated by Sanger 
sequencing (Additional file 2: Table S2). The PCSK5 gene 
has five transcript variants (splice variants/isoforms) 
according to the Ensembl database [17], and we called the 
mutations according to the longest transcript, PCSK5-
201 (ENST00000545128). The frameshift mutation was 
c.4870_4871delTG (p.C1624fs) and a missense mutation 
was c.4876C>A (p.Q1626K) (Figure  1). The other two 
missense mutations only appeared in transcript PCSK5-
003 (ENST00000376767) and we called them c.2027G>C 
(p.W676S) and c.2032G>C (p.G678R), respectively.
Two missense mutations in exon 14 of the PCSK5-003 
transcript (p.W676S and p.G678R) were also present in the 
patient’s mother. The genomic region of these elements was 
located within a short simple repeat of (GAATG)n (Chro-
mosome 9: 78790113-78790255, 143 bp) according to the 
RepeatMasker of the UCSC genome browser (http://www.
repeatmasker.org/). These missense mutations were found 
to occur due to repeat number variations of 5-nucleo-
tide repeats since there were nucleotide variations in each 
repeat unit (Figure  2a). The 5-nucleotide repeats were 
transcribed only in the PCSK5-003 isoform. The evolu-
tional conservation of the elements in which the mutations 
were detected was analyzed by multiple alignments using 
the UCSC genome browser [17], and this region demon-
strated no conservation across species (Figure  3a). Taken 
together, these mutations are unlikely to affect the function 
of the gene product. Whereas the dbSNP database con-
tains a single submission for these mutations (rs62556590, 
rs77249767) [20], those of HapMap-JPT, 1000 Genomes 
(including ASN) [21], and HGVD have no such entries.
A frameshift mutation and the other missense muta-
tion were also present in the boy’s father (Figure  2b). 
Although the dbSNP and 1000 Genomes databases do 
not contain records of the frameshift or the missense 
mutations in exons 34 (PCSK5-201) or 28 (PCSK5-002), 
the HGVD has entries for 4 and 2 identical mutant alleles, 
respectively, among a total of 858 alleles (allele fre-
quency: 0.5 and 0.2%, respectively). Both mutations were 
located in the PCSK5-201 and PCSK5-002 isoforms. The 
frameshift mutation results in a truncated protein that 
disrupts a region highly conserved across species (Fig-
ure 3b), suggesting that it might cause a functional altera-
tion of PCSK5. The position of the missense mutation 
(p.Q1626K) may not be significant because it is located 
downstream of the frameshift mutation (Figure 2b).
PCSK5 proteins are composed of 3 or 4 domains 
according to predictions by the InterPro database version 
46.0 [22] (Figure  1). The protein domain that included 
the frameshift mutation was that of an insulin-like 
growth factor binding protein (IPR009030) containing 
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a cysteine-rich motif (CRM). CRMs are found in a vari-
ety of eukaryotic proteins that are involved in receptor 
tyrosine kinase signaling. CRMs are also considered to 
be responsible for interactions with cell surface heparan 
sulfate proteoglycans (HSPGs) via tissue inhibitors of 
metalloproteases (TIMPs) [5]. The frameshift mutation 
converts a cysteine residue to a stop codon to produce a 
truncated protein with the loss of the C-terminal half of 
the CRM domain or a loss of protein production due to 
nonsense-mediated mRNA decay.
Since we identified the p.C1624fs (PCSK5-201) 
frameshift mutation in the database for the general pop-
ulation (HGVD), we next searched for other possible 
deleterious mutations in the PCSK5 gene (Additional 
file 2: Table S2). We identified two nonsense mutations, 
c.3052C>T (p.Q1018X, rs373172614) and c.4615C>T 
(p.R1539X, rs140709872), in the PCSK5 gene in the vari-
ant database from the general population. The frequency 
of these variants is 0.02%, which is several-fold higher 
than that of the VACTERL association. We also identi-
fied five frameshift mutations, c.1490_1491insACAC 
(p.N497fs rs138544337), c.1496_1497insC (p.R500fs, 
rs372197834), c.3915_3916insG (p.V1307fs, rs34898066), 
c.4665_4666insG (p.Y1557fs, rs34889598), and 
c.5095_5096insCC (p.D1699fs, rs138280866), in the gen-
eral population. Altogether, it appears that the mutation 
in the PCSK5 gene might be innocuous and not associ-
ated with the VACTERL association.
Discussion and conclusion
PCSK5 is a proprotein convertase enzyme that cleaves 
prohormones at consensus sequences [23–25]. PCSK5 
is expressed in somites, the dorsal surface ectoderm, and 
primordial vertebral cartilage [23], as well as in the skel-
etal regions of the developing vertebrae, limbs, and crani-
ofacium [24]. Recessive PCSK5 mutant mice induced 
by ethylnitrosourea exhibited hypoplastic hindlimbs, 
absent tail, cardiac malformations, palatal agenesis, tra-
cheoesophageal malformation, pulmonary hypoplasia, 
exomphalos, and renal agenesis [15], and epiblast-spe-
cific PCSK5 conditional knockout mice using Meox2Cre 
showed similar phenotypes [26]. These findings demon-
strate that PCSK5 plays a pivotal role in skeletogenesis 
and organogenesis in mice. Meanwhile, non-synonymous 
PCSK5 mutations were implicated in 4 of the 36 cases of 
the VACTERL association in humans reported by Szum-
ska et al. and in 3 of the 39 cases described by Winberg 
et al. [14, 15].
Figure 1 Exon and protein domain structures of the PCSK5 gene. The transcripts and their exon structures are based on the Ensembl database 
(ENSG00000099139). Ensembl transcript IDs are shown in brackets. The protein domain structures are based on the InterPro database. InterPro 
domain IDs are shown in the legend with notes. The locations of the detected mutations are indicated by black arrows.
Page 5 of 7Nakamura et al. BMC Res Notes  (2015) 8:228 
It has also been reported that GDF11 is involved in 
murine skeletogenesis [27]. PCSK5 can cleave the GDF11 
propeptide into its mature form [16], which suggests that 
PCSK5 activates GDF11 in mice. Mutant PCSK5 proteins 
were seen to not cleave the pro-protein of GDF11 [27]. 
In addition, GDF11 knockout mice showed absent tail, 
palatal agenesis, renal agenesis, and increased numbers 
of thoracic vertebrae and ribs, all of which resembled the 
phenotypes of PCSK5-deficient mice [15]. Therefore, it 
is likely that the mechanism by which such phenotypes 
are observed in mice is via an inability to produce active 
GDF11 [15].
We witnessed a novel frameshift mutation in the PCSK5 
gene in our patient with the VACTERL association. Since 
three heterozygous missense mutations [14], four het-
erozygous missense mutations, and one homozygous mis-
sense mutation in the PCSK5 gene [15] were previously 
reported in patients with the VACTERL association, we 
first thought this might be a strong candidate gene that 
was responsible for the patient’s phenotype. However, 
this is improbable for several reasons: (1) the healthy 
father also carries this mutation, (2) databases for the 
general population include this frameshift mutation, and 
(3) databases for the general population include not only 
this mutation, but also other deleterious mutations in the 
PCSK5 gene, such as nonsense and frameshift mutations. 
Furthermore, the frequency of these variants is several-
fold higher than that of the VACTERL association. A 
recessive trait was unlikely for the VACTERL association 
since there have been no previous reports on the simul-
taneous occurrence of this condition in siblings. Taken 
together, the PCSK5 mutation appears to be benign and 
unrelated to the etiology of the VACTERL association.
It remains possible that the effect of the PCSK5 
frameshift mutation observed in this study might be 
dominant with incomplete penetrance. To date, Winberg 
and other groups have suggested that detected PCSK5 
variants could represent pathogenic entities with reduced 
penetrance [14, 15]. It is also possible that the mater-
nally transmitted missense mutation, although innocu-
ous alone, can affect phenotype when combined with the 
paternal frameshift mutation. Further mutations or copy 
number variations in other genes might have affected 
phenotype as well. Moreover, since the etiology of the 
VACTERL association is believed to be multifactorial, 
both modifier genes and environmental factors, such as 
Figure 2 Novel PCSK5 frameshift mutation in the patient as demonstrated by Sanger sequencing. a Two novel missense mutations are validated 
and show inheritance from the maternal allele. Note that another missense mutation just downstream of the two missense mutations is observed 
in the child, but not in the mother. The mutations are located in exon 14 of transcript PCSK5-003 (ENST00000376767). b A frameshift mutation is 
validated and shows inheritance from the paternal allele. The mutation is located in exon 34 of transcript PCSK5-201 (ENST00000545128) or exon 
28 of transcript PCSK5-002 (ENST00000424854). Just after the frameshift, a cysteine codon is changed to a stop codon, which suggests a functional 
impact on this gene. Another missense mutation (c.4876C > A [p.Q1626K], c.3976C > A [p.Q1326K]) is validated in exon 34 but is presumed to be 
functionally irrelevant due to the upstream stop codon.
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hyperglycemia, may have precluded the development of 
this malformation [28].
In addition to the PCSK5 mutations, we identified two 
de novo mutations in our patient. One was identified in 
the NT5C3L gene encoding a cytosolic nucleotidase-like 
protein, which might play a role in RNA metabolism. 
The other was harbored in the TTLL9 gene encoding a 
ciliary protein that may act in tubulin glutamylation [29, 
30]. Since ciliary genes are involved in some human mal-
formation syndromes, they represent another candidate 
gene responsible for the patient’s phenotype. Further 
studies are necessary to clarify the elusive etiology of the 
VACTERL association.
Authors’ contributions
SK, SS, MT, NI, HT, MM, FF, HI, TK, TK, HK, and HK participated in the design of 
the study and helped to draft the manuscript. YN conceived of the study, and 
Additional files
Additional file 1: Table S1. CARE Checklist (2013) of information to 
include when writing a case report.
Additional file 2: Table S2. Summary of the mutations identified in the 
subjects and database.
participated in its design and coordination and helped to draft the manu-
script. All authors read and approved the final manuscript.
Author details
1 Department of Orthopaedic Surgery, Shinshu University School of Medicine, 
Matsumoto, Japan. 2 DNA Chip Research Inc., Kanagawa, Japan. 3 Department 
of Orthopaedic Surgery, Faculty of Medicine, University of Toyama, Toyama, 
Japan. 4 Department of Orthopaedic Surgery, Hokkaido University School 
of Medicine, Sapporo, Japan. 5 Department of Orthopaedic Surgery, Osaka City 
University Graduate School of Medicine, Osaka, Japan. 6 Department of Ortho-
paedic Surgery, Nagano Prefectural Children’s Hospital, Azumino, Japan. 7 Divi-
sion of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita 
Health University, Toyoake, Japan. 8 Endocrine Unit, Massachusetts General 
Hospital and Harvard Medical School, Boston, MA, USA. 
Acknowledgements
This study was supported by grants from the Takeda Science Foundation, the 
Japan Orthopaedics and Traumatology Foundation, Inc. (No.227), the Kanae 
Foundation for the Promotion of Medical Science, and the Naito Foundation 
to Y.N.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Consent for publication 
Written informed consent was obtained from the patient for publication of 
this Case report and any accompanying images. A copy of the written consent 
is available for review by the Editor of this journal.
Figure 3 Evolutionary conservation of the region containing the frameshift mutation in the PCSK5 gene. a Two novel missense mutations in exon 
14 of PCSK5-003 inherited from the maternal allele have no conservation across species. b The frameshift mutation in exon 34 (PCSK5-201)/28 
(PCSK5-002) derived from the paternal allele affects highly conserved residues. The p.Q1626K (PCSK5-201)/p.Q1326K (PCSK5-002) mutation exhibits 
conservation among primates, but may be functionally irrelevant due to an upstream frameshift mutation.
Page 7 of 7Nakamura et al. BMC Res Notes  (2015) 8:228 
Received: 2 February 2015   Accepted: 12 May 2015
References
 1. Solomon BD (2011) VACTERL/VATER Association. Orphanet J Rare Dis 6:56
 2. Reardon W, Zhou XP, Eng C (2001) A novel germline mutation of the PTEN 
gene in a patient with macrocephaly, ventricular dilatation, and features 
of VATER association. J Med Genet 38:820e3
 3. Garcia-Barceló MM, Wong KK, Lui VC, Yuan ZW, So MT, Ngan ES et al 
(2008) Identification of a HOXD13 mutation in a VACTERL patient. Am J 
Med Genet 146A:3181e5
 4. Stankiewicz P, Sen P, Bhatt SS, Storer M, Xia Z, Bejjani BA et al (2009) 
Genomic and genic deletions of the FOX gene cluster on 16q24.1 and 
inactivating mutations of FOXF1 cause alveolar capillary dysplasia and 
other malformations. Am J Hum Genet 84:780–791
 5. Wessels MW, Kuchinka B, Heydanus R, Smit BJ, Dooijes D, de Krijger RR 
et al (2010) Polyalanine expansion in the ZIC3 gene leading to X- linked 
heterotaxy with VACTERL association: a new polyalanine dis- order? J 
Med Genet 47:351–355
 6. McCauley J, Masand N, McGowan R, Rajagopalan S, Hunter A, Michaud 
JL et al (2011) X-linked VACTERL with hydrocephalus syndrome: further 
delineation of the phenotype caused by FANCB mutations. Am J Med 
Genet 155A:2370–2380
 7. Saisawat P, Kohl S, Hilger AC, Hwang DY, Yung Gee H, Dworschak GC 
et al (2014) Whole-exome resequencing reveals recessive mutations in 
TRAP1 in individuals with CAKUT and VACTERL association. Kidney Int 
85:1310–1317
 8. Chung B, Shaffer LG, Keating S, Johnson J, Casey B, Chitayat D (2011) 
From VACTERL-H to heterotaxy: variable expressivity of ZIC3-related 
disorders. Am J Med Genet A 155A:1123–1128
 9. Schramm C, Draaken M, Bartels E, Boemers TM, Aretz S, Brockschmidt 
FF et al (2011) De novo microduplication at 22q11.21 in a patient with 
VACTERL association. Eur J Med Genet 54:9–13
 10. Hilger A, Schramm C, Pennimpede T, Wittler L, Dworschak GC, Bartels E 
et al (2013) De novo microduplications at 1q41, 2q37.3, and 8q24.3 in 
patients with VATER/VACTERL association. Eur J Hum Genet 21:1377–1382
 11. Dworschak GC, Draaken M, Marcelis C, de Blaauw I, Pfundt R, van Rooij 
IA et al (2013) De novo 13q deletions in two patients with mild anorectal 
malformations as part of VATER/VACTERL and VATER/VACTERL-like asso-
ciation and analysis of EFNB2 in patients with anorectal malformations. 
Am J Med Genet A 161A:3035–3041
 12. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM et al (2010) 
Exome sequencing identifies the cause of a mendelian disorder. Nat 
Genet 42:30–35
 13. Rabbani B, Tekin M, Mahdieh N (2014) The promise of whole-exome 
sequencing in medical genetics. J Hum Genet 59:5–15
 14. Winberg J, Gustavsson P, Papadogiannakis N, Sahlin E, Bradley F, Norden-
skjöld E et al (2014) Mutation Screening and Array Comparative Genomic 
Hybridization Using a 180 K Oligonucleotide Array in VACTERL Associa-
tion. PLoS One 9:e85313
 15. Szumska D, Pieles G, Essalmani R, Bilski M, Mesnard D, Kaur K et al (2008) 
VACTERL/caudal regression/Currarino syndrome-like malformations 
in mice with mutation in the proprotein convertase Pcsk5. Genes Dev 
22:1465–1477
 16. Li H, Durbin R (2009) Fast and accurate short read alignment with 
Burrows-Wheeler transform. Bioinformatics 25:1754–1760
 17. Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S et al (2014) Ensembl 
2014. Nucleic Acids Res 42 (Database issue): D749–D755
 18. Cingolani P, Platts A, le Wang L, Coon M, Nguyen T, Wang L et al (2012) A 
program for annotating and predicting the effects of single nucleotide 
polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster 
strain w1118; iso-2; iso-3”. Fly (Austin) 6:80–92
 19. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL (2012) 
Primer-BLAST: a tool to design target-specific primers for polymerase 
chain reaction. BMC Bioinform 13:134
 20. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM et al 
(2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 
29:308–311
 21. 1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, 
DePristo MA, Durbin RM et al (2012) An integrated map of genetic varia-
tion from 1,092 human genomes. Nature 491:56–65
 22. Zdobnov EM, Apweiler R (2001) InterProScan—an integration plat-
form for the signature-recognition methods in InterPro. Bioinformatics 
17:847–848
 23. Constam DB, Calfon M, Robertson EJ (1996) SPC4, SPC6, and the novel 
protease SPC7 are coexpressed with bone morphogenetic proteins at 
distinct sites during embryogenesis. J Cell Biol 134:181–191
 24. Rancourt SL, Rancourt DE (1997) Murine subtilisin-like proteinase SPC6 is 
expressed during embryonic implantation, somitogenesis, and skeletal 
formation. Dev Genet 21:75–81
 25. Essalmani R, Zaid A, Marcinkiewicz J, Chamberland A, Pasquato A, Seidah 
NG et al (2008) In vivo functions of the proprotein convertase PC5/6 
during mouse development: Gdf11 is a likely substrate. Proc Natl Acad Sci 
USA 105:5750–5755
 26. Essalmani R, Hamelin J, Marcinkiewicz J, Chamberland A, Mbikay M, 
Chrétien M et al (2006) Deletion of the gene encoding proprotein con-
vertase 5/6 causes early embryonic lethality in the mouse. Mol Cell Biol 
26:354–361
 27. McPherron AC, Lawler AM, Lee SJ (1999) Regulation of anterior/posterior 
patterning of the axial skeleton by growth/differentiation factor 11. Nat 
Genet 22:260–264
 28. Solomon BD (2011) VACTERL/VATER Association. Orphanet J Rare Dis. 
16(6):56. doi:10.1186/1750-1172-6-56 (Review)
 29. Wloga D, Rogowski K, Sharma N, Van Dijk J, Janke C, Eddé B et al (2008) 
Glutamylation on alpha-tubulin is not essential but affects the assembly 
and functions of a subset of microtubules in Tetrahymena thermophila. 
Eukaryot Cell 7:1362–1372
 30. Kubo T, Yanagisawa HA, Yagi T, Hirono M, Kamiya R (2010) Tubulin poly-
glutamylation regulates axonemal motility by modulating activities of 
inner-arm dyneins. Curr Biol 20:441–445
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
